文献速递高血压血脂与心血管预防

利用遗传学指导高血压钠钾干预

Using Genetics to Inform Interventions Related to Sodium and Potassium in Hypertension.
PubMed 文献 · Circulation · 2023-12-22

结果显示尿钠与钠钾通路遗传风险存在交互作用,高遗传风险者尿钠升高与收缩压升高幅度更大,而常规全基因组多基因评分无此交互。提示钠钾通路遗传风险可用于精准医学模型指导高血压干预。

要点

  • 尿钠与钠钾通路遗传风险对收缩压存在交互作用。
  • 高遗传风险者尿钠每增加1个标准差,收缩压升高1.47毫米汞柱。
  • 常规全基因组多基因评分与尿钠无强交互证据。

核心结论

  • 钠钾通路遗传风险可能用于精准医学模型,更特异性地指导高血压干预。

主要发现

  • 遗传风险和尿电解质均独立与血压相关。
  • 尿钠与钠钾转运通路遗传风险存在交互作用:尿钠每增加1个标准差,遗传风险最高10%者收缩压升高1.47毫米汞柱,最低10%者升高0.97毫米汞柱(P=1.95×10-3)。
  • 该交互作用在考虑估算肾小球滤过率和尿钠/尿肌酐比值后仍存在。
  • 尿钠与标准全基因组多基因评分之间无强交互证据。

临床怎么用

  • 可考虑利用钠钾通路遗传风险识别可能从限钠和增钾干预中获益更多的高血压个体。

局限性

  • 为观察性横断面研究,干预研究尚待开展。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hypertension is a key risk factor for major adverse cardiovascular events but remains difficult to treat in many individuals. Dietary interventions are an effective approach to lower blood pressure (BP) but are not equally effective across all individuals. BP is heritable, and genetics may be a useful tool to overcome treatment response heterogeneity. We investigated whether the genetics of BP could be used to identify individuals with hypertension who may receive a particular benefit from lowering sodium intake and boosting potassium levels. METHODS: In this observational genetic study, we leveraged cross-sectional data from up to 296 475 genotyped individuals drawn from the UK Biobank cohort for whom BP and urinary electrolytes (sodium and potassium), biomarkers of sodium and potassium intake, were measured. Biologically directed genetic scores for BP were constructed specifically among pathways related to sodium and potassium biology (pharmagenic enrichment scores), as well as unannotated genome-wide scores (conventional polygenic scores). We then tested whether there was a gene-by-environment interaction between urinary electrolytes and these genetic scores on BP. RESULTS: Genetic risk and urinary electrolytes both independently correlated with BP. However, urinary sodium was associated with a larger BP increase among individuals with higher genetic risk in sodium- and potassium-related pathways than in those with comparatively lower genetic risk. For example, each SD in urinary sodium was associated with a 1.47-mm Hg increase in systolic BP for those in the top 10% of the distribution of genetic risk in sodium and potassium transport pathways versus a 0.97-mm Hg systolic BP increase in the lowest 10% (P=1.95×10-3). This interaction with urinary sodium remained when considering estimated glomerular filtration rate and indexing sodium to urinary creatinine. There was no strong evidence of an interaction between urinary sodium and a standard genome-wide polygenic score of BP. CONCLUSIONS: The data suggest that genetic risk in sodium and potassium pathways could be used in a precision medicine model to direct interventions more specifically in the management of hypertension. Intervention studies are warranted.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Reay WR, Clarke E, Eslick S, et al. Using Genetics to Inform Interventions Related to Sodium and Potassium in Hypertension. Circulation. 2023. PMID: 38131187. doi:10.1161/CIRCULATIONAHA.123.065394

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。